Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1536-1546

  Naji, Abderrahim ^a,b   Menier, Catherine ^a,b   Morandi, Fabio ^b   Agaugué, Sophie ^a,b   Maki, Guitta ^a,b   Ferretti, Elisa ^c   Bruel, Sylvie ^a,b   Pistoia, Vito ^c   Carosella, Edgardo D ^a,b   Rouas Freiss, Nathalie ^a,b  

^a DIF   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; CELL PROTEIN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; GLYCOGEN SYNTHASE KINASE 3BETA; HLA G ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 2 INHIBITORY RECEPTOR; PROTEIN ITIM; PROTEIN KINASE B; RAF PROTEIN; RECEPTOR; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GERMINAL CENTER; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; T LYMPHOCYTE; TH2 CELL; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; G1 PHASE CELL CYCLE CHECKPOINTS; GERMINAL CENTER; GLYCOGEN SYNTHASE KINASE 3; HLA-G ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PALATINE TONSIL; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, CXCR4; RECEPTORS, CXCR5; RECEPTORS, IMMUNOLOGIC; TH2 CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84896719009     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300438     Document Type: Article

References (44)

1. Harwood, N. E., and F. D. Batista. 2008. New insights into the early molecular events underlying B cell activation. Immunity 28: 609-619.
2. Mitchison, N. A. 2004. T-cell-B-cell cooperation. Nat. Rev. Immunol. 4: 308-312.
3. McCubrey, J. A., L. S. Steelman, S. L. Abrams, F. E. Bertrand, D. E. Ludwig, J. Bäsecke, M. Libra, F. Stivala, M. Milella, A. Tafuri, et al. 2008. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia 22: 708-722.
4. Rawlings, D. J., M. A. Schwartz, S. W. Jackson, and A. Meyer-Bahlburg. 2012. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12: 282-294.
5. Dalakas, M. C. 2008. Invited article: inhibition of B cell functions: implications for neurology. Neurology 70: 2252-2260.
6. Redfield, R. R., III, E. Rodriguez, R. Parsons, K. Vivek, M. M. Mustafa, H. Noorchashm, and A. Naji. 2011. Essential role for B cells in transplantation tolerance. Curr. Opin. Immunol. 23: 685-691.
7. Liu, C., H. Noorchashm, J. A. Sutter, M. Naji, E. L. Prak, J. Boyer, T. Green, M. R. Rickels, J. E. Tomaszewski, B. Koeberlein, et al. 2007. B lymphocytedirected immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat. Med. 13: 1295-1298.
8. Dighiero, G., and T. J. Hamblin. 2008. Chronic lymphocytic leukaemia. Lancet 371: 1017-1029.
9. Kurosaki, T. 2008. Paradox of B cell-targeted therapies. J. Clin. Invest. 118: 3260-3263.
10. Colonna, M., F. Navarro, T. Bellón, M. Llano, P. García, J. Samaridis, L. Angman, M. Cella, and M. López-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809-1818.
11. Shiroishi, M., K. Kuroki, L. Rasubala, K. Tsumoto, I. Kumagai, E. Kurimoto, K. Kato, D. Kohda, and K. Maenaka. 2006. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc. Natl. Acad. Sci. USA 103: 16412-16417.
12. Shiroishi, M., K. Kuroki, T. Ose, L. Rasubala, I. Shiratori, H. Arase, K. Tsumoto, I. Kumagai, D. Kohda, and K. Maenaka. 2006. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 281: 10439-10447.
13. Riteau, B., N. Rouas-Freiss, C. Menier, P. Paul, J. Dausset, and E. D. Carosella. 2001. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J. Immunol. 166: 5018-5026.
14. Lila, N., N. Rouas-Freiss, J. Dausset, A. Carpentier, and E. D. Carosella. 2001. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc. Natl. Acad. Sci. USA 98: 12150-12155.
15. Le Rond, S., C. Azéma, I. Krawice-Radanne, A. Durrbach, C. Guettier, E. D. Carosella, and N. Rouas-Freiss. 2006. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J. Immunol. 176: 3266-3276.
16. Naji, A., A. Durrbach, E. D. Carosella, and N. Rouas-Freiss. 2007. Soluble HLAG and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways. Hum. Immunol. 68: 233-239.
17. Liang, S., V. Ristich, H. Arase, J. Dausset, E. D. Carosella, and A. Horuzsko. 2008. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6 - STAT3 signaling pathway. Proc. Natl. Acad. Sci. USA 105: 8357-8362.
18. Carosella, E. D., P. Moreau, J. Lemaoult, and N. Rouas-Freiss. 2008. HLA-G: from biology to clinical benefits. Trends Immunol. 29: 125-132.
19. Moreau, P., S. Flajollet, and E. D. Carosella. 2009. Non-classical transcriptional regulation of HLA-G: an update. J. Cell. Mol. Med. 13(9B): 2973-2989.
20. Rouas-Freiss, N., R. M. Gonçalves, C. Menier, J. Dausset, and E. D. Carosella. 1997. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA 94: 11520-11525.
21. Carosella, E. D., P. Moreau, S. Aractingi, and N. Rouas-Freiss. 2001. HLA-G: a shield against inflammatory aggression. Trends Immunol. 22: 553-555.
22. Morandi, F., I. Levreri, P. Bocca, B. Galleni, L. Raffaghello, S. Ferrone, I. Prigione, and V. Pistoia. 2007. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Cancer Res. 67: 6433-6441.
23. Jinquan, T., H. H. Jacobi, C. Jing, A. Millner, E. Sten, L. Hviid, L. Anting, L. P. Ryder, C. Glue, P. S. Skov, et al. 2003. CCR3 expression induced by IL-2 and IL-4 functioning as a death receptor for B cells. J. Immunol. 171: 1722-1731.
24. Liu, Y. J., D. E. Joshua, G. T. Williams, C. A. Smith, J. Gordon, and I. C. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centres. Nature 342: 929-931.
25. Lebecque, S., O. de Bouteiller, C. Arpin, J. Banchereau, and Y. J. Liu. 1997. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J. Exp. Med. 185: 563-571.
26. Menier, C., C. Guillard, B. Cassinat, E. D. Carosella, and N. Rouas-Freiss. 2008. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera. Leukemia 22: 578-584.
27. Bekeredjian-Ding, I., S. Inamura, T. Giese, H. Moll, S. Endres, A. Sing, U. Zähringer, and G. Hartmann. 2007. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J. Immunol. 178: 2803-2812.
28. Corcione, A., L. Ottonello, G. Tortolina, P. Facchetti, I. Airoldi, R. Guglielmino, P. Dadati, M. Truini, S. Sozzani, F. Dallegri, and V. Pistoia. 2000. Stromal cellderived factor-1 as a chemoattractant for follicular center lymphoma B cells. J. Natl. Cancer Inst. 92: 628-635.
29. Kim, H. S., X. Zhang, and Y. S. Choi. 1994. Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes. J. Immunol. 153: 2951-2961.
30. Hauser, A. E., T. Junt, T. R. Mempel, M. W. Sneddon, S. H. Kleinstein, S. E. Henrickson, U. H. von Andrian, M. J. Shlomchik, and A. M. Haberman. 2007. Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity 26: 655-667.
31. Ghebrehiwet, B., L. Silvestri, and C. McDevitt. 1984. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J. Exp. Med. 160: 1375-1389.
32. Naji, A., C. Menier, G. Maki, E. D. Carosella, and N. Rouas-Freiss. 2012. Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction. Leukemia 26: 1889-1892.
33. Cross, D. A., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
34. Greer, E. L., and A. Brunet. 2005. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425.
35. Bléry, M., H. Kubagawa, C. C. Chen, F. Vély, M. D. Cooper, and E. Vivier. 1998. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 95: 2446-2451.
36. Ristich, V., S. Liang, W. Zhang, J. Wu, and A. Horuzsko. 2005. Tolerization of dendritic cells by HLA-G. Eur. J. Immunol. 35: 1133-1142.
37. Liang, S., B. Baibakov, and A. Horuzsko. 2002. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur. J. Immunol. 32: 2418-2426.
38. Gonen-Gross, T., H. Achdout, R. Gazit, J. Hanna, S. Mizrahi, G. Markel, D. Goldman-Wohl, S. Yagel, V. Horejsí, O. Levy, et al. 2003. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J. Immunol. 171: 1343-1351.
39. Naji, A., S. Le Rond, A. Durrbach, I. Krawice-Radanne, C. Creput, M. Daouya, J. Caumartin, J. LeMaoult, E. D. Carosella, and N. Rouas-Freiss. 2007. CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 110: 3936-3948.
40. Qiu, J., P. I. Terasaki, J. Miller, K. Mizutani, J. Cai, and E. D. Carosella. 2006. Soluble HLA-G expression and renal graft acceptance. Am. J. Transplant. 6: 2152-2156.
41. Sheshgiri, R., V. Rao, A. Mociornita, H. J. Ross, and D. H. Delgado. 2010. Association between HLA-G expression and C4d staining in cardiac transplantation. Transplantation 89: 480-481.
42. Tamir, I., J. M. Dal Porto, and J. C. Cambier. 2000. Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction. Curr. Opin. Immunol. 12: 307-315.
43. Feger, U., E. Tolosa, Y. H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl. 2007. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 110: 568-577.
44. Wiendl, H., U. Feger, M. Mittelbronn, C. Jack, B. Schreiner, C. Stadelmann, J. Antel, W. Brueck, R. Meyermann, A. Bar-Or, B. C. Kieseier, and M. Weller. 2005. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 128: 2689-2704.